GEODE CAPITAL MANAGEMENT, LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2023$11,590
+89053.8%
27,1770.0%0.00%
Q4 2022$13
-99.8%
27,1770.0%0.00%
Q3 2022$8,000
-55.6%
27,1770.0%0.00%
Q2 2022$18,000
-58.1%
27,1770.0%0.00%
Q1 2022$43,000
-12.2%
27,1770.0%0.00%
Q4 2021$49,000
-34.7%
27,1770.0%0.00%
Q3 2021$75,000
+25.0%
27,177
+36.2%
0.00%
Q2 2021$60,000
-11.8%
19,9600.0%0.00%
Q1 2021$68,000
+9.7%
19,9600.0%0.00%
Q4 2020$62,000
-11.4%
19,9600.0%0.00%
Q3 2020$70,000
-26.3%
19,9600.0%0.00%
Q2 2020$95,000
+37.7%
19,9600.0%0.00%
Q1 2020$69,000
-70.0%
19,960
-50.0%
0.00%
Q4 2019$230,000
+142.1%
39,920
+100.0%
0.00%
Q3 2019$95,000
-34.9%
19,9600.0%0.00%
Q2 2019$146,000
+2.8%
19,960
+14.7%
0.00%
Q1 2019$142,000
-11.2%
17,397
-25.9%
0.00%
Q4 2018$160,000
+0.6%
23,492
+100.0%
0.00%
Q3 2018$159,000
+14.4%
11,7460.0%0.00%
Q2 2018$139,000
-37.7%
11,746
-60.0%
0.00%
Q4 2015$223,000
+10.4%
29,374
+7.7%
0.00%
Q3 2015$202,000
-26.0%
27,269
+0.3%
0.00%
Q2 2015$273,000
+7.1%
27,177
+0.2%
0.00%
Q1 2015$255,000
+121.7%
27,131
+36.0%
0.00%
Q4 2014$115,000
-32.4%
19,955
+0.7%
0.00%
Q3 2014$170,000
+9.0%
19,817
+23.3%
0.00%
Q2 2014$156,00016,0770.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 202,100$2,318,0001.99%
Gerry Farber, LLC 52,000$596,0001.03%
Granite Point Capital Management, L.P. 115,000$1,319,0000.94%
683 Capital Management, LLC 158,735$1,821,0000.71%
SPHERA FUNDS MANAGEMENT LTD. 170,000$1,950,0000.44%
Knoll Capital Management, LLC 65,000$746,0000.39%
Healthcare Value Capital, LLC 50,000$574,0000.38%
Park West Asset Management LLC 200,000$2,294,0000.26%
Perceptive Advisors 75,000$860,0000.09%
HIGHLAND CAPITAL MANAGEMENT LP 126,956$1,456,0000.06%
View complete list of GALMED PHARMACEUTICALS LTD shareholders